Page 157 - GPD-4-1
P. 157

Gene & Protein in Disease                                         FXR1 modulates gene expression in cancer




















































            Figure  6.  Co-expression network analysis of FXR1 using GeneMANIA. The network, generated using GeneMANIA, illustrates FXR1’s functional
            interactions, including co-expression, physical interactions, shared protein domains, and predicted relationships with other genes. The red lines indicate
            physical interactions, the purple lines represent co-expression, the blue lines represent co-localization, the green lines indicate genetic interactions, the
            orange lines represent predicted interactions, and the gray lines denote other biological associations.

            as shown in the boxplots (Figure 7A). This overexpression   that the high expression of these genes, driven by FXR1,
            suggests a potential oncogenic role for these genes.   correlates with poorer prognosis, making them potential
            Transcriptome sequencing data from the TCGA and GTEx   biomarkers for cancer aggressiveness and candidates for
            databases identified SLC43A3, ACKR3, KCNN3, LEMD1,   targeted therapy.
            GPR35,  WNT7A,  F2RL3,  and  ANO5 as independent
            risk factors for OS. The Kaplan-Meier  survival curve   In contrast, we found that NBAT1, PDZK1IP1, NECAB2,
            demonstrated that patients with high expression of these   ATOH8, and IGFBP7 were downregulated in tumor tissues
            genes had significantly shorter OS than those with low   compared to normal tissues, as shown by the boxplots
            expression levels (Figure 7A). The high-expression group   (Figure 8). The Kaplan-Meier survival curve demonstrated
            shows a rapid decline in survival probability over time,   that patients with low expression of these genes had shorter
            suggesting that overexpression of these genes is associated   OS  compared  to  those  with  higher  expression  levels
            with poor prognosis in cancer patients. Furthermore, as   (Figure 8). Notably, FXR1 is also implicated in regulating
            previous analyses indicate, FXR1 plays a regulatory role   the  expression of  these  genes;  it  likely  destabilizes  or
            in the expression of these genes. FXR1 likely promotes the   promotes the degradation of these mRNAs, leading to
            stabilization or upregulation of these mRNAs, contributing   their reduced expression in tumor tissues. These findings
            to their oncogenic potential. These findings suggest   indicate that low expression of these genes, influenced by


            Volume 4 Issue 1 (2025)                         11                              doi: 10.36922/gpd.5068
   152   153   154   155   156   157   158   159   160   161   162